Abstract |
During initial trials of 5-azacytidine in adults with advanced acute leukemia, we unexpectedly observed acid-base, fluid, and electrolyte abnormalities that contributed directly to the deaths of two early patients. To evaluate this toxicity further, we studied 22 patients who received a total of 33 courses of combination chemotherapy that included 5-azacytidine. During 29 courses (88%) of treatment, polyuria, glucosuria, and/or transient changes in the serum concentrations of bicarbonate or phosphorus were detected. Spontaneous polyuria with demonstrable salt wasting and orthostatic hypotension occurred during seven courses (21%) of treatment. Inappropriate glucosuria was observed in nine courses (27%). In 24 courses (73%) the serum bicarbonate fell below the normal range. The urine became alkaline during 12 of these instances; the anion gap was not increased during the acidosis. Hypophosphatemia with serum phosphorus concentrations as low as 0.3 mg/dl occurred in 21 of 32 evaluable courses (66%). In the three patients studied the tubular reabsorption of phosphorus was 10%-18%. The renal abnormalities that were observed suggest both proximal and distal tubular damage from 5-azacytidine. Patients receiving 5-azacytidine should be monitored closely for manifestations of renal toxicity.
|
Authors | B A Peterson, A J Collins, N J Vogelzang, C D Bloomfield |
Journal | Blood
(Blood)
Vol. 57
Issue 1
Pg. 182-5
(Jan 1981)
ISSN: 0006-4971 [Print] United States |
PMID | 6160887
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Bicarbonates
- Phosphorus
- Sodium
- Azacitidine
- Potassium
|
Topics |
- Acute Disease
- Adolescent
- Adult
- Aged
- Azacitidine
(adverse effects, therapeutic use)
- Bicarbonates
(blood)
- Glycosuria
(physiopathology)
- Humans
- Kidney Tubules
(physiopathology)
- Leukemia
(drug therapy)
- Middle Aged
- Phosphorus
(blood, urine)
- Polyuria
(chemically induced)
- Potassium
(blood)
- Sodium
(blood)
|